Company Filing History:

15 out of 449

Alcon Laboratories, Inc.

patents

4 out of 81

Alcon Manufacturing, Ltd.

Years Active: 1986-2005

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6936640 - Biguanide/quaternary ammonium containing copolymeric biocides and use thereof in pharmaceutical compositions (2005-08-30),

2. 6916958 - Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions (2005-07-12),

3. 6664294 - Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions (2003-12-16),

4. 6423748 - Amido polybiguanides and the use thereof as antimicrobial agents (2002-07-23),

5. 6316669 - Bis-amido polybiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions (2001-11-13),

6. 6051611 - Polymeric quaternary ammonium compounds and their use as ophthalmic (2000-04-18),

7. 5900213 - Use of diamines to disinfect and clean contact lenses and preserve (1999-05-04),

8. 5868868 - Peg-modified proteases and methods of use in contact lens cleaning (1999-02-09),

9. 5631005 - Use of amidoamines in ophthalmic compositions (1997-05-20),

10. 5573726 - Use of amidoamines in ophthalmic compositions (1996-11-12),

11. 5536494 - Polyethylene oxide-containing quaternary ammunium polymers and (1996-07-16),

12. 5399737 - Quaternary ammonium siloxane compounds and methods for their use (1995-03-21),

13. 5393491 - Use of amidoamines in ophthalmic compositions (1995-02-28),

14. 5300287 - Polymeric antimicrobials and their use in pharmaceutical compositions (1994-04-05),

15. 5133745 - Ultraviolet absorbing hydrogels (1992-07-28),

Title: Innovator Spotlight: Joonsup Park - Pioneering Ophthalmic Biocides

Introduction:

Joonsup Park, a prolific inventor based in Arlington, TX, has left an indelible mark on the field of pharmaceutical compositions with his groundbreaking work in developing biocides for ophthalmic applications. With an impressive portfolio of 20 patents to his name, Park's contributions have significantly advanced the field of antimicrobial agents.

Latest Patents:

Park's recent patents include innovations such as Biguanide/quaternary ammonium containing copolymeric biocides and their application in pharmaceutical compositions. These compounds have proven invaluable in preserving ophthalmic pharmaceutical compositions and disinfecting contact lenses. Additionally, his work on aminobiguanides for disinfecting contact lenses further underscores his dedication to improving eye care solutions.

Career Highlights:

Having worked at esteemed companies like Alcon Laboratories, Inc. and Alcon Manufacturing, Ltd., Park has honed his expertise in the development and application of biocides in pharmaceutical products. His tenure at these organizations has provided him with the platform to spearhead innovative projects that have reshaped the industry's approach to antimicrobial solutions.

Collaborations:

Throughout his career, Park has collaborated with talented individuals such as Joseph J Falcetta and Nissanke L Dassanayake. Together, they have leveraged their collective expertise to push the boundaries of ophthalmic biocide development and enhance the efficacy of pharmaceutical compositions for eye care.

Conclusion:

Joonsup Park's relentless pursuit of innovation and his commitment to advancing the field of ophthalmic biocides have solidified his reputation as a trailblazer in the pharmaceutical industry. With a rich tapestry of patents and a legacy of transformative contributions, Park continues to inspire future generations of inventors to push the boundaries of what is possible in pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com